That's why I find it significant that the three musketeers, Gabriel, Gomez, and Bookbinder, all three Managing Partners in Genbiomics, find themselves in the Bio/Pharma validation arm of Semaphore in November 2002. The next thing you know, wham, they are deeply involved in the inner workings of DNAP, and seem to be transforming the organization.
W2P---This was the big kicker for me. I know what kind of
person Doc T is. Bright brainy rebel---once the heavy weights
came on board---well the plan came together and we had a winner. JMHO but I am in for the long haul.
Take Care
Arch